EpiVax Launches Precision Cancer Immunotherapy Venture, EpiVax Oncology – Markets Insider
|
EpiVax Launches Precision Cancer Immunotherapy Venture, EpiVax Oncology
Markets Insider EpiVax has provided $500,000 in seed funding and has provided exclusive access to enabling technologies to the new precision immunotherapy venture. Gad Berdugo MSc Eng., MBA will lead EpiVax Oncology as Chief Executive Officer. Gad brings over 25 … |
